Glen Pater
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Medical and Regulatory Affairs, AstraZeneca Australia, PO Box 131, North Ryde, NSW 1670.
Correspondence: Glen.Pater@ASTRAZENECA.COM
- 1. Nordman IC, Spillane AJ, Hamilton AL. The aromatase inhibitors in early breast cancer: who, when and why? Med J Aust 2005; 183: 24-27.<eMJA full text>
Online responses are no longer available. Please refer to our instructions for authors page for more information.